Michael A. Mussallem
Chairman & CEO at Edwards Lifesciences Corporation
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Edwards Lifesciences Corporation, 3 years.
Edwards Lifesciences Corporation
Director · Chairman & CEO
Chief executive roles
Edwards Lifesciences Corporation
· Chairman & CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 2, 2024 | Edwards Lifesciences Corporation | Option exercise | +29,350 | $36.75 | $1,078,613 |
| May 2, 2024 | Edwards Lifesciences Corporation | Open-market sale | −12,207 | $85.02 | $1,037,839 |
| May 2, 2024 | Edwards Lifesciences Corporation | Open-market sale | −17,143 | $84.59 | $1,450,126 |
| Apr 4, 2024 | Edwards Lifesciences Corporation | Option exercise | +29,350 | $36.75 | $1,078,613 |
| Apr 4, 2024 | Edwards Lifesciences Corporation | Open-market sale | −200 | $94.19 | $18,838 |
| Apr 4, 2024 | Edwards Lifesciences Corporation | Open-market sale | −2,712 | $93.72 | $254,169 |
| Apr 4, 2024 | Edwards Lifesciences Corporation | Open-market sale | −9,820 | $91.54 | $898,923 |
| Apr 4, 2024 | Edwards Lifesciences Corporation | Open-market sale | −16,618 | $92.70 | $1,540,489 |
| Mar 4, 2024 | Edwards Lifesciences Corporation | Option exercise | +29,350 | $36.75 | $1,078,613 |
| Mar 4, 2024 | Edwards Lifesciences Corporation | Open-market sale | −13,310 | $86.21 | $1,147,455 |
| Mar 4, 2024 | Edwards Lifesciences Corporation | Open-market sale | −16,040 | $87.05 | $1,396,282 |
| Feb 5, 2024 | Edwards Lifesciences Corporation | Option exercise | +29,350 | $36.75 | $1,078,613 |
| Feb 5, 2024 | Edwards Lifesciences Corporation | Open-market sale | −1,000 | $89.61 | $89,610 |
| Feb 5, 2024 | Edwards Lifesciences Corporation | Open-market sale | −6,422 | $88.63 | $569,182 |
| Feb 5, 2024 | Edwards Lifesciences Corporation | Open-market sale | −9,761 | $86.44 | $843,741 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.